Literature DB >> 15909252

Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

Rocus R Klont1, Cathrien A Eggink, Antonius J M M Rijs, Pieter Wesseling, Paul E Verweij.   

Abstract

A case of invasive Fusarium keratitis in a previously healthy male patient was treated successfully with cornea transplantation and systemic and topical voriconazole after treatment failure with topical amphotericin B and systemic itraconazole. Topical voriconazole was well tolerated, and, in conjunction with the oral administration, it resulted in a high level of the drug in the anterior chamber of the eye (which was 160% of the plasma drug level).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909252     DOI: 10.1086/430062

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  16 in total

1.  Topical voriconazole as a novel treatment for fungal keratitis.

Authors:  William Sponsel; Nancy Chen; Demi Dang; Gianmarco Paris; John Graybill; Laura K Najvar; Lei Zhou; Kwok-Wai Lam; Randolph Glickman; Frank Scribbick
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  The use of voriconazole in the treatment of Aspergillus fumigatus keratitis.

Authors:  Rosalind M K Stewart; Say Aun Quah; Timothy J Neal; Stephen B Kaye
Journal:  Br J Ophthalmol       Date:  2007-08       Impact factor: 4.638

3.  Prospective open-label study of the administration of two-percent voriconazole eye drops.

Authors:  Daoud Al-Badriyeh; Lok Leung; Trent Roydhouse; Robert Fullinfaw; Mark Daniell; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

4.  Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.

Authors:  Michael A Thiel; Annelies S Zinkernagel; Jürgen Burhenne; Claude Kaufmann; Walter E Haefeli
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

5.  Comparison of natamycin and voriconazole for the treatment of fungal keratitis.

Authors:  Namperumalsamy V Prajna; Jeena Mascarenhas; Tiruvengada Krishnan; P Ravindranath Reddy; Lalitha Prajna; Muthiah Srinivasan; C M Vaitilingam; Kevin C Hong; Salena M Lee; Stephen D McLeod; Michael E Zegans; Travis C Porco; Thomas M Lietman; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2010-06

6.  Corneal Cross-Linking Has No Effect on Matrix Metalloproteinase 9 and 13 Levels During Fungal Keratitis on the Early Stage.

Authors:  Ayse Kalkanci; Kamil Bilgihan; Huseyin Baran Ozdemir; Atiye Seda Yar Saglam; Funda Karakurt; Merve Erdogan
Journal:  Mycopathologia       Date:  2017-10-17       Impact factor: 2.574

7.  Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis.

Authors:  Daoud Al-Badriyeh; Chin Fen Neoh; Kay Stewart; David C M Kong
Journal:  Clin Ophthalmol       Date:  2010-05-06

Review 8.  Voriconazole : a review of its use in the management of invasive fungal infections.

Authors:  Lesley J Scott; Dene Simpson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Antifungal efficacy of voriconazole, itraconazole and amphotericin b in experimental fusarium solani keratitis.

Authors:  Güliz Fatma Yavas; Faruk Oztürk; Tuncay Küsbeci; Zafer Cetinkaya; Sitki Samet Ermis; Nuri Kiraz; Umit Ubeyt Inan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-10-02       Impact factor: 3.117

10.  Aqueous humor concentration of voriconazole after topical administration in rabbits.

Authors:  Christian K Vorwerk; F Streit; L Binder; S Tuchen; C Knop; W Behrens-Baumann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-20       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.